Janux Therapeutics, Inc. - Common Stock — Cash Flow (NASDAQ:JANX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -16.98 M-42.92 M-50.58 M-43.81 M-82.23 M -77.55 M Cash from investing activities -340.96 M58.27 M-41.19 M-258.02 M-300.98 M 47.7 M Cash from financing activities 386.52 M500 K59.55 M713.24 M4.95 M 7.94 M Free cash flow -16.98 M-42.92 M-50.58 M-43.81 M-83.28 M -78.49 M

News

Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know

Here's Why You Should Add JANX Stock to Your Portfolio Now

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

Undercovered Stocks: Western Digital, SAP, Toast And More

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value (JANX)

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY)

Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?

Will Higher Costs & Lower Occupancy Impact HCA's Q1 Earnings?

Stocks Retreat on Middle East Peace Doubts

Will Health Benefits Weakness Drag Elevance's Q1 Earnings?

Truist cuts Janux Therapeutics stock price target on competition